1887
Rapid communication Open Access
Like 0

Abstract

A reassortant influenza A subtype H1N2 virus with gene segments from seasonal A(H1N1)pdm09 virus (HA, MP, NP, NS, PA, PB1 and PB2) and seasonal A(H3N2) virus (NA) was identified in a routine surveillance sample in Denmark. The patient recovered fully. This is the second reassortant influenza A(H1N2) virus identified in Europe in the 2018/19 influenza season, with the first case being detected December 2018 in Sweden.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.27.1900406
2019-07-04
2024-12-26
/content/10.2807/1560-7917.ES.2019.24.27.1900406
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/27/eurosurv-24-27-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.27.1900406&mimeType=html&fmt=ahah

References

  1. Trebbien R, Pedersen SS, Vorborg K, Franck KT, Fischer TK. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014. Euro Surveill. 2017;22(3):30445.  https://doi.org/10.2807/1560-7917.ES.2017.22.3.30445  PMID: 28128091 
  2. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol. 2009;83(19):10309-13.  https://doi.org/10.1128/JVI.01109-09  PMID: 19605485 
  3. European Centre for Disease Prevention and Control (ECDC). Technical note. Influenza virus characterisation guidelines for the northern hemisphere influenza season 2018-2019. Tessy. Stockholm: ECDC; October 2018.
  4. Wiman Å, Enkirch T, Carnahan A, Böttiger B, Hagey TS, Hagstam P, et al. Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019. Euro Surveill. 2019;24(9):1900124.  https://doi.org/10.2807/1560-7917.ES.2019.24.9.1900124  PMID: 30862332 
  5. Meijer A, Swaan CM, Voerknecht M, Jusic E, van den Brink S, Wijsman LA, et al. Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018. Euro Surveill. 2018;23(15):1800160.  https://doi.org/10.2807/1560-7917.ES.2018.23.15.18-00160  PMID: 29667576 
  6. Komadina N, McVernon J, Hall R, Leder K. A historical perspective of influenza A(H1N2) virus. Emerg Infect Dis. 2014;20(1):6-12.  https://doi.org/10.3201/eid2001.121848  PMID: 24377419 
  7. Gregianini TS, Varella IRS, Fisch P, Martins LG, Veiga ABG. Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil. J Infect Dis. 2019:jiz221.  https://doi.org/10.1093/infdis/jiz221  PMID: 31125400 
  8. Szymański K, Cieślak K, Kowalczyk D, Brydak LB. Co-infection with Influenza Viruses and Influenza-Like Virus During the 2015/2016 Epidemic Season. Adv Exp Med Biol. 2017;968:7-12.  https://doi.org/10.1007/5584_2016_182  PMID: 28181195 
  9. Joseph U, Su YC, Vijaykrishna D, Smith GJ. The ecology and adaptive evolution of influenza A interspecies transmission. Influenza Other Respir Viruses. 2017;11(1):74-84.  https://doi.org/10.1111/irv.12412  PMID: 27426214 
  10. Caini S, Spreeuwenberg P, Kusznierz GF, Rudi JM, Owen R, Pennington K, et al. Global Influenza B Study group. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. BMC Infect Dis. 2018;18(1):269.  https://doi.org/10.1186/s12879-018-3181-y  PMID: 29884140 
  11. Kissling E, Rose A, Emborg HD, Gherasim A, Pebody R, Pozo F, et al. European Ive Group. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019;24(8):1900121.  https://doi.org/10.2807/1560-7917.ES.2019.24.1900121  PMID: 30808440 
  12. Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. MMWR Morb Mortal Wkly Rep. 2019;68(6):135-9.  https://doi.org/10.15585/mmwr.mm6806a2  PMID: 30763298 
  13. Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, et al. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill. 2019;24(4):1900055.  https://doi.org/10.2807/1560-7917.ES.2019.24.4.1900055  PMID: 30696523 
  14. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291-300.  https://doi.org/10.1016/S1473-3099(09)70069-6  PMID: 19393959 
  15. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725-9.  https://doi.org/10.1093/molbev/mst197  PMID: 24132122 
/content/10.2807/1560-7917.ES.2019.24.27.1900406
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error